Read twice and referred to the Committee on Finance.
This bill would amend the Social Security Act to bar use of federal Medicaid and CHIP funds for a defined set of “specified gender transition procedures.” The prohibited items include a long list of surgical procedures (e.g., vaginoplasty, phalloplasty, mastectomy, hysterectomy, orchiectomy), placement of certain implants, certain gluteal procedures, and administration or dispensing of puberty blockers and supraphysiologic doses of sex hormones. The bill creates limited exceptions for treatment of precocious puberty and for medically necessary interventions tied to disorders of sex development, certain complications, or life‑threatening conditions, and it defines “male” and “female” in biological reproductive terms.
Scope of coverage: liberals see broad harm to access for transgender patients, conservatives view the bill as appropriate restriction of federal funding.
Relative to its intended legislative type, this bill is a substantive statutory prohibition on federal Medicaid and CHIP funding for specified gender transition procedures.
This bill would amend the Social Security Act to bar use of federal Medicaid and CHIP funds for a defined set of “specified gender transition procedures.” The prohibited items include a long list of surgical procedures (e.g., vaginoplasty, phalloplasty, mastectomy, hysterectomy, orchiectomy), placement of certain implants, certain gluteal procedures, and administration or dispensing of puberty blockers and supraphysiologic doses of sex hormones.
The bill creates limited exceptions for treatment of precocious puberty and for medically necessary interventions tied to disorders of sex development, certain complications, or life‑threatening conditions, and it defines “male” and “female” in biological reproductive terms.
The statutory change would make those expenditures ineligible for federal Medicaid and CHIP reimbursement; the bill is titled the “Stop Funding Genital Mutilation Act.”
On content alone, this is a politically charged, targeted prohibition that lacks broad compromise mechanisms and would provoke strong advocacy and legal scrutiny. While technically concise and limited to federal reimbursement (which can be a legislative lever), the high ideological salience, likely opposition from stakeholders in healthcare and civil‑rights communities, and implementation ambiguities make enactment unlikely absent broader legislative tradeoffs or major shifts in legislative priorities.
Relative to its intended legislative type, this bill is a substantive statutory prohibition on federal Medicaid and CHIP funding for specified gender transition procedures. It includes detailed, enumerated definitions and directly amends the Social Security Act to accomplish that prohibition.
Scope of coverage: liberals see broad harm to access for transgender patients, conservatives view the bill as appropriate restriction of federal funding.
These are examples from the analysis, not a ranked list of the most-affected groups.
Scope of coverage: liberals see broad harm to access for transgender patients, conservatives view the bill as appropriate restriction of federal funding.
A mainstream progressive observer would view this bill as a federal ban on Medicaid and CHIP reimbursement for gender-affirming care that disproportionately affects low-income and young transgender people.
They would note the broad scope (surgeries, implants, puberty blockers, and cross-sex hormones) and worry the exceptions are narrow and framed in a way that excludes many gender‑dysphoric patients.
They would likely characterize the bill as restricting access to medically recommended care and anticipate increases in health disparities and possible harm to mental and physical health among affected people.
A pragmatic, moderate observer would see this bill as a clear federal restriction on what Medicaid and CHIP can reimburse and would weigh concerns about federal overreach, health impacts, and fiscal implications.
They would note the bill’s broad list of prohibited items and the narrowness of some exceptions, and worry about implementation details—how states, providers, and beneficiaries will respond.
They would likely be open to reasonable limits on specific pediatric interventions if grounded in clinical evidence, but would want clearer definitions, guardrails for medically necessary adult care, and an assessment of fiscal and access consequences.
A mainstream conservative observer would likely view the bill favorably as a measure to prevent federal funding of gender-transition procedures, which they may characterize as medically unnecessary or harmful—especially for minors.
They would see the bill’s explicit list of procedures and drug classes as addressing a perceived policy gap and view the statutory definition of sex and the parental-consent framing of exceptions as supportive of their policy goals.
They would likely appreciate the federal- funding lever to incentivize states to limit Medicaid/CHIP coverage of these interventions and see this as consistent with protecting traditional norms and limiting federal expenditures on controversial treatments.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, this is a politically charged, targeted prohibition that lacks broad compromise mechanisms and would provoke strong advocacy and legal scrutiny. While technically concise and limited to federal reimbursement (which can be a legislative lever), the high ideological salience, likely opposition from stakeholders in healthcare and civil‑rights communities, and implementation ambiguities make enactment unlikely absent broader legislative tradeoffs or major shifts in legislative priorities.
The bill has not accumulated any surfaced votes yet.
Scope of coverage: liberals see broad harm to access for transgender patients, conservatives view the bill as appropriate restriction of fe…
On content alone, this is a politically charged, targeted prohibition that lacks broad compromise mechanisms and would provoke strong advoc…
Relative to its intended legislative type, this bill is a substantive statutory prohibition on federal Medicaid and CHIP funding for specified gender transition procedures. It includes detailed, enumerated definitions a…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.